HR Notices From April 29The latest staffing, leadership and boardroom news from Michigan's technology-focused companies, institutions and groups
HR Notices From February 15The latest staffing, leadership and boardroom news from Michigan's technology-focused companies and institutions
Lycera Achieves First Milestone in Merck Research CollaborationLycera Corp., a biopharmaceutical company creating innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has reached the first milestone under its research collaboration with Merck, triggering a milestone payment.
HR Notices From October 4The latest staffing and boardroom news from Michigan's technology-focused companies and institutions
Lycera Management to Present at Upcoming ConferencesPlymouth-based Lycera Corp., a biopharmaceutical company developing new medicines to treat autoimmune diseases, will present at several industry conferences this fall
Lycera Graduates from Incubator to North Campus Research ComplexLycera, a biopharmaceutical company and University of Michigan spinoff, plans to partner and collaborate with U-M faculty and students with a move to UM’s North Campus Research Complex.
Lycera Announces Research Collaboration with MerckThe Plymouth-based biopharmaceutical developer Lycera Corp. Thursday announced an exclusive research collaboration with pharma giant Merck to develop drug candidates that have the potential to treat major autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis